CJ Filed Injunction To End Trademark Dispute

Published: 2004-12-10 06:57:00

Updated: 2004-12-10 06:57:00

In an effort to put a final closure on its controversial trademark dispute with Hanmi Pharmaceutical, CJ Pharmaceutical Division filed for an injunction with the Seoul Central District Court on December 6th.

The Korea Intellectual Property Office (KIPO) made a decision on September 30th of thi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK